Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Net Income (2016 - 2025)

Historic Net Income for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $44.7 million.

  • Haemonetics' Net Income rose 1932.58% to $44.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $175.4 million, marking a year-over-year increase of 3486.37%. This contributed to the annual value of $167.7 million for FY2025, which is 4262.83% up from last year.
  • Latest data reveals that Haemonetics reported Net Income of $44.7 million as of Q4 2025, which was up 1932.58% from $38.7 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Net Income ranged from a high of $58.0 million in Q1 2025 and a low of -$11.0 million during Q2 2021
  • In the last 5 years, Haemonetics' Net Income had a median value of $32.1 million in 2022 and averaged $27.5 million.
  • In the last 5 years, Haemonetics' Net Income crashed by 16261.2% in 2021 and then surged by 54627.3% in 2022.
  • Quarter analysis of 5 years shows Haemonetics' Net Income stood at $14.8 million in 2021, then surged by 122.13% to $32.9 million in 2022, then fell by 5.15% to $31.2 million in 2023, then rose by 20.06% to $37.5 million in 2024, then increased by 19.33% to $44.7 million in 2025.
  • Its Net Income stands at $44.7 million for Q4 2025, versus $38.7 million for Q3 2025 and $34.0 million for Q2 2025.